Dr. Nazha is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
550 Peachtree St NE
Ste 1820
Atlanta, GA 30308Phone+1 404-778-1900
Education & Training
Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2020
Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 2017
Columbia UniversityMPH, Health Policy and Management, 2014
American University of Beirut Faculty of MedicineClass of 2013, MD- McGill UniversityBS, Biology, Great Distinction, 2008
Certifications & Licensure
GA State Medical License 2020 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma Start of enrollment: 2021 May 20
Roles: Principal Investigator, Contact
- Cabozantinib in Combination With Atezolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer Start of enrollment: 2024 Mar 05
Roles: Contact, Principal Investigator
- Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology Start of enrollment: 2023 Sep 26
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Real-World Outcomes in Patients with Advanced Penile Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Single Institution Experience.Tony Z Zhuang, Subir Goyal, Katherine B Case, T Anders Olsen, Shalini Vemuru
Journal of Immunotherapy and Precision Oncology. 2025-02-01 - Trop-2 and Ephrin B2 expression in urothelial carcinoma with divergent differentiation and aggressive urothelial carcinoma subtypes.Katherine B Case, Dylan J Martini, Melad N Dababneh, Samuel Bidot, Bassel Nazha
American Journal of Clinical Pathology. 2024-12-20 - Characteristics, Treatment, and Outcomes of Primary Urethral Cancer: A Multicenter Review Over Two Decades.Benjamin D Hopkins, David C Qian, Karen M Xu, Ashley McCook-Veal, Jeffrey Switchenko
Clinical Genitourinary Cancer. 2024-11-28
Press Mentions
The Case for Immunotherapy Trials That Reflect the Real World of Metastatic MelanomaSeptember 13th, 2019
With Millions at Stake, Oncologists Question Ethics of New Billing PracticeMay 14th, 2024
Other Languages
- French, Arabic
External Links
- Winship Cancer Institute profilehttps://winshipcancer.emory.edu/bios/faculty/nazha-bassel.html
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
